The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Stem Cells-Global Market Insights and Sales Trends 2025
Synopsis
Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).
The global Stem Cells market size is expected to reach US$ 5727.2 million by 2029, growing at a CAGR of 10.9% from 2023 to 2029. The market is mainly driven by the significant applications of Stem Cells in various end use industries. The expanding demands from the Blood Disease, Cancer, Autoimmune Disease and Others, are propelling Stem Cells market. Stem Cell Storage, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Stem Cell Pharmaceutical and Treatment segment is estimated at % CAGR for the next seven-year period.
Stem cell industry of the world's major players have Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi - post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen, Takeda (TiGenix), CBR, ViaCord, Esperite, LifeCell, CCBC, VCANBIO, BOYA LIFE, Beike Biotechnology and International Medical, etc, It has a total market share of 45%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Stem Cells, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Stem Cells market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Stem Cells market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Stem Cells sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Stem Cells covered in this report include Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi-post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen and Takeda (TiGenix), etc.
The global Stem Cells market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Osiris Therapeutics
NuVasive
Chiesi Pharmaceuticals
Medi-post
JCR Pharmaceutical
MolMed
Pharmicell
Anterogen
Takeda (TiGenix)
CBR
ViaCord
Esperite
LifeCell
CCBC
VCANBIO
BOYA LIFE
Beike Biotechnology
International Medical
Global Cord Blood Corporation
Beijing Health-Biotech Group
ABMD
Global Stem Cells market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Stem Cells market, Segment by Type:
Stem Cell Storage
Stem Cell Pharmaceutical and Treatment
Global Stem Cells market, by Application
Blood Disease
Cancer
Autoimmune Disease
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Stem Cells companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).
The global Stem Cells market size is expected to reach US$ 5727.2 million by 2029, growing at a CAGR of 10.9% from 2023 to 2029. The market is mainly driven by the significant applications of Stem Cells in various end use industries. The expanding demands from the Blood Disease, Cancer, Autoimmune Disease and Others, are propelling Stem Cells market. Stem Cell Storage, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Stem Cell Pharmaceutical and Treatment segment is estimated at % CAGR for the next seven-year period.
Stem cell industry of the world's major players have Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi - post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen, Takeda (TiGenix), CBR, ViaCord, Esperite, LifeCell, CCBC, VCANBIO, BOYA LIFE, Beike Biotechnology and International Medical, etc, It has a total market share of 45%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Stem Cells, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Stem Cells market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Stem Cells market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Stem Cells sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Stem Cells covered in this report include Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi-post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen and Takeda (TiGenix), etc.
The global Stem Cells market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Osiris Therapeutics
NuVasive
Chiesi Pharmaceuticals
Medi-post
JCR Pharmaceutical
MolMed
Pharmicell
Anterogen
Takeda (TiGenix)
CBR
ViaCord
Esperite
LifeCell
CCBC
VCANBIO
BOYA LIFE
Beike Biotechnology
International Medical
Global Cord Blood Corporation
Beijing Health-Biotech Group
ABMD
Global Stem Cells market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Stem Cells market, Segment by Type:
Stem Cell Storage
Stem Cell Pharmaceutical and Treatment
Global Stem Cells market, by Application
Blood Disease
Cancer
Autoimmune Disease
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Stem Cells companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Stem Cells
1.1 Stem Cells Market Overview
1.1.1 Stem Cells Product Scope
1.1.2 Stem Cells Market Status and Outlook
1.2 Global Stem Cells Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Stem Cells Market Size by Region (2018-2029)
1.4 Global Stem Cells Historic Market Size by Region (2018-2023)
1.5 Global Stem Cells Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Stem Cells Market Size (2018-2029)
1.6.1 North America Stem Cells Market Size (2018-2029)
1.6.2 Europe Stem Cells Market Size (2018-2029)
1.6.3 Asia-Pacific Stem Cells Market Size (2018-2029)
1.6.4 Latin America Stem Cells Market Size (2018-2029)
1.6.5 Middle East & Africa Stem Cells Market Size (2018-2029)
2 Stem Cells Market by Type
2.1 Introduction
2.1.1 Stem Cell Storage
2.1.2 Stem Cell Pharmaceutical and Treatment
2.2 Global Stem Cells Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Stem Cells Historic Market Size by Type (2018-2023)
2.2.2 Global Stem Cells Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Stem Cells Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Stem Cells Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Stem Cells Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Stem Cells Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Stem Cells Revenue Breakdown by Type (2018-2029)
3 Stem Cells Market Overview by Application
3.1 Introduction
3.1.1 Blood Disease
3.1.2 Cancer
3.1.3 Autoimmune Disease
3.1.4 Others
3.2 Global Stem Cells Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Stem Cells Historic Market Size by Application (2018-2023)
3.2.2 Global Stem Cells Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Stem Cells Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Stem Cells Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Stem Cells Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Stem Cells Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Stem Cells Revenue Breakdown by Application (2018-2029)
4 Stem Cells Competition Analysis by Players
4.1 Global Stem Cells Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Stem Cells as of 2022)
4.3 Date of Key Players Enter into Stem Cells Market
4.4 Global Top Players Stem Cells Headquarters and Area Served
4.5 Key Players Stem Cells Product Solution and Service
4.6 Competitive Status
4.6.1 Stem Cells Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Osiris Therapeutics
5.1.1 Osiris Therapeutics Profile
5.1.2 Osiris Therapeutics Main Business
5.1.3 Osiris Therapeutics Stem Cells Products, Services and Solutions
5.1.4 Osiris Therapeutics Stem Cells Revenue (US$ Million) & (2018-2023)
5.1.5 Osiris Therapeutics Recent Developments
5.2 NuVasive
5.2.1 NuVasive Profile
5.2.2 NuVasive Main Business
5.2.3 NuVasive Stem Cells Products, Services and Solutions
5.2.4 NuVasive Stem Cells Revenue (US$ Million) & (2018-2023)
5.2.5 NuVasive Recent Developments
5.3 Chiesi Pharmaceuticals
5.3.1 Chiesi Pharmaceuticals Profile
5.3.2 Chiesi Pharmaceuticals Main Business
5.3.3 Chiesi Pharmaceuticals Stem Cells Products, Services and Solutions
5.3.4 Chiesi Pharmaceuticals Stem Cells Revenue (US$ Million) & (2018-2023)
5.3.5 Medi-post Recent Developments
5.4 Medi-post
5.4.1 Medi-post Profile
5.4.2 Medi-post Main Business
5.4.3 Medi-post Stem Cells Products, Services and Solutions
5.4.4 Medi-post Stem Cells Revenue (US$ Million) & (2018-2023)
5.4.5 Medi-post Recent Developments
5.5 JCR Pharmaceutical
5.5.1 JCR Pharmaceutical Profile
5.5.2 JCR Pharmaceutical Main Business
5.5.3 JCR Pharmaceutical Stem Cells Products, Services and Solutions
5.5.4 JCR Pharmaceutical Stem Cells Revenue (US$ Million) & (2018-2023)
5.5.5 JCR Pharmaceutical Recent Developments
5.6 MolMed
5.6.1 MolMed Profile
5.6.2 MolMed Main Business
5.6.3 MolMed Stem Cells Products, Services and Solutions
5.6.4 MolMed Stem Cells Revenue (US$ Million) & (2018-2023)
5.6.5 MolMed Recent Developments
5.7 Pharmicell
5.7.1 Pharmicell Profile
5.7.2 Pharmicell Main Business
5.7.3 Pharmicell Stem Cells Products, Services and Solutions
5.7.4 Pharmicell Stem Cells Revenue (US$ Million) & (2018-2023)
5.7.5 Pharmicell Recent Developments
5.8 Anterogen
5.8.1 Anterogen Profile
5.8.2 Anterogen Main Business
5.8.3 Anterogen Stem Cells Products, Services and Solutions
5.8.4 Anterogen Stem Cells Revenue (US$ Million) & (2018-2023)
5.8.5 Anterogen Recent Developments
5.9 Takeda (TiGenix)
5.9.1 Takeda (TiGenix) Profile
5.9.2 Takeda (TiGenix) Main Business
5.9.3 Takeda (TiGenix) Stem Cells Products, Services and Solutions
5.9.4 Takeda (TiGenix) Stem Cells Revenue (US$ Million) & (2018-2023)
5.9.5 Takeda (TiGenix) Recent Developments
5.10 CBR
5.10.1 CBR Profile
5.10.2 CBR Main Business
5.10.3 CBR Stem Cells Products, Services and Solutions
5.10.4 CBR Stem Cells Revenue (US$ Million) & (2018-2023)
5.10.5 CBR Recent Developments
5.11 ViaCord
5.11.1 ViaCord Profile
5.11.2 ViaCord Main Business
5.11.3 ViaCord Stem Cells Products, Services and Solutions
5.11.4 ViaCord Stem Cells Revenue (US$ Million) & (2018-2023)
5.11.5 ViaCord Recent Developments
5.12 Esperite
5.12.1 Esperite Profile
5.12.2 Esperite Main Business
5.12.3 Esperite Stem Cells Products, Services and Solutions
5.12.4 Esperite Stem Cells Revenue (US$ Million) & (2018-2023)
5.12.5 Esperite Recent Developments
5.13 LifeCell
5.13.1 LifeCell Profile
5.13.2 LifeCell Main Business
5.13.3 LifeCell Stem Cells Products, Services and Solutions
5.13.4 LifeCell Stem Cells Revenue (US$ Million) & (2018-2023)
5.13.5 LifeCell Recent Developments
5.14 CCBC
5.14.1 CCBC Profile
5.14.2 CCBC Main Business
5.14.3 CCBC Stem Cells Products, Services and Solutions
5.14.4 CCBC Stem Cells Revenue (US$ Million) & (2018-2023)
5.14.5 CCBC Recent Developments
5.15 VCANBIO
5.15.1 VCANBIO Profile
5.15.2 VCANBIO Main Business
5.15.3 VCANBIO Stem Cells Products, Services and Solutions
5.15.4 VCANBIO Stem Cells Revenue (US$ Million) & (2018-2023)
5.15.5 VCANBIO Recent Developments
5.16 BOYA LIFE
5.16.1 BOYA LIFE Profile
5.16.2 BOYA LIFE Main Business
5.16.3 BOYA LIFE Stem Cells Products, Services and Solutions
5.16.4 BOYA LIFE Stem Cells Revenue (US$ Million) & (2018-2023)
5.16.5 BOYA LIFE Recent Developments
5.17 Beike Biotechnology
5.17.1 Beike Biotechnology Profile
5.17.2 Beike Biotechnology Main Business
5.17.3 Beike Biotechnology Stem Cells Products, Services and Solutions
5.17.4 Beike Biotechnology Stem Cells Revenue (US$ Million) & (2018-2023)
5.17.5 Beike Biotechnology Recent Developments
5.18 International Medical
5.18.1 International Medical Profile
5.18.2 International Medical Main Business
5.18.3 International Medical Stem Cells Products, Services and Solutions
5.18.4 International Medical Stem Cells Revenue (US$ Million) & (2018-2023)
5.18.5 International Medical Recent Developments
5.19 Global Cord Blood Corporation
5.19.1 Global Cord Blood Corporation Profile
5.19.2 Global Cord Blood Corporation Main Business
5.19.3 Global Cord Blood Corporation Stem Cells Products, Services and Solutions
5.19.4 Global Cord Blood Corporation Stem Cells Revenue (US$ Million) & (2018-2023)
5.19.5 Global Cord Blood Corporation Recent Developments
5.20 Beijing Health-Biotech Group
5.20.1 Beijing Health-Biotech Group Profile
5.20.2 Beijing Health-Biotech Group Main Business
5.20.3 Beijing Health-Biotech Group Stem Cells Products, Services and Solutions
5.20.4 Beijing Health-Biotech Group Stem Cells Revenue (US$ Million) & (2018-2023)
5.20.5 Beijing Health-Biotech Group Recent Developments
5.21 ABMD
5.21.1 ABMD Profile
5.21.2 ABMD Main Business
5.21.3 ABMD Stem Cells Products, Services and Solutions
5.21.4 ABMD Stem Cells Revenue (US$ Million) & (2018-2023)
5.21.5 ABMD Recent Developments
6 North America
6.1 North America Stem Cells Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Stem Cells Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Stem Cells Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Stem Cells Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Stem Cells Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Stem Cells Market Dynamics
11.1 Stem Cells Industry Trends
11.2 Stem Cells Market Drivers
11.3 Stem Cells Market Challenges
11.4 Stem Cells Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
